TCT-417 Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis

Roisin Colleran,Sebastian Kufner,Michael D. Joner,Janika Bohner,Felix Altevogt,Franz-Josef Neumann,Christian Valina,Mohamed Abdel-Wahab,Gert Richardt,Salvatore Cassese,Tareq Ibrahim,Heribert Schunkert,Karl-Ludwig Laugwitz,Adnan Kastrati,Robert A. Byrne

TCT-417 Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis

2017

Roisin Colleran
Sebastian Kufner
Michael D. Joner
Janika Bohner
Felix Altevogt
Franz-Josef Neumann
Christian Valina
Mohamed Abdel-Wahab
Gert Richardt
Salvatore Cassese
Tareq Ibrahim
Heribert Schunkert
Karl-Ludwig Laugwitz
Adnan Kastrati
Robert A. Byrne

Angioplasty with drug-coated balloons (DCB) is recommended for treatment of coronary in-stent restenosis (ISR) in European clinical practice guidelines. However there is a paucity of study data comparing different DCB devices. Our aim was to compare the performance of two widely-used paclitaxel-

Keywords:

Excipient
Clinical Practice
Restenosis
Internal medicine
Paclitaxel
Stent
Angioplasty
Cardiology
Medicine
in patient
in stent restenosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations